Hypervascular malignant tumor
Conditions
Interventions
Experimental group:Perform TACE procedure using embolic microspheres
Sponsors
Zhongshan Hospital Affiliated to Fudan University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Subjects must meet all of the following criteria to be included: 1. Age >= 18 years, any gender; 2. Investigator deems suitable for using contrast-loaded microspheres; 3. Patient has at least one measurable tumor lesion; 4. Willing to undergo a 3-month follow-up; 5. Agree to participate in this clinical trial and voluntarily sign the informed consent form.
Exclusion criteria
Exclusion criteria: Subjects who meet any of the following exclusion criteria cannot be enrolled in this study: 1. Severe infection that cannot be effectively controlled; 2. ECOG PS score >2, cachexia, or multi-organ failure; 3. Known severe allergy to iodine contrast agents or embolic materials; 4. Pregnant or breastfeeding women, or those planning to conceive; 5. Lack of autonomous decision-making ability.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Objective response rate of target lesions; | — |
Secondary
| Measure | Time frame |
|---|---|
| Visibility performance of radiopaque drug-eluting beads;Intratumoral Distribution Rate of Radiopaque Drug-Eluting Beads;Disease Control Rate (DCR) of Target Lesions; | — |
Countries
China
Contacts
Public ContactQu Xudong
Zhongshan Hospital Affiliated to Fudan University
Outcome results
None listed